Celltrion, Inc.

ANVIGLOBE

Pharmaceutical preparations; antibody treatment preparations; pharmaceuticals; drugs for medical purposes;

AVTOZMA

Immunosuppressant; drugs for medical purposes; pharmaceuticals; pharmaceutical preparations;

BILTRUZO

Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticals, namely, pharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticals, namely, pharmaceutical preparations for the treatment of HIV/AIDS;Color is not claimed as a feature of the mark.;

BLITZIMA

pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammations; pharmaceutical preparations for the treatment of transplant rejection; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases;BLITZ IMA;

DIATRUST

Diagnostic apparatus for medical purposes for testing for viruses; Diagnostic instruments for medical purposes for testing for viruses; Diagnostic equipment for medical purposes for testing for viruses; in vitro diagnostic equipment for testing for viruses;

EMBRACELIFE

Provision of educational courses of instruction in the field of diet and health care; instruction in the use and operation of medical products; teaching in the field of medical products; providing of on-line non-downloadable electronic publications via mobile devices in the nature of brochures in the field of health care;EMBRACE LIFE;

EMBRACELIFE

Downloadable computer software applications for providing information on drugs and diseases, scheduling and reminding medication dosing;EMBRACE LIFE;

EMBRACELIFE

EMBRACE LIFE;health care; medical counseling to provide information on drugs and diseases, scheduling and reminding medication dosing;

EMISIMA

Pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders;

EMISIMA

Pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders;

EYDENZELT

Ophthalmic preparations; pharmaceutical preparations for the treatment of angiogenesis;The wording EYDENZELT has no meaning in a foreign language.;

FLIXCELI

Pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders;FLIX CELI;

FLIXCELI

Pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders;

HERTUGEN

Pharmaceutical preparations and compositions for treatment of cancer;

HERTUMAB

Pharmaceutical preparations and compositions for treatment of cancer;

HERTUZU

Pharmaceutical preparations for the treatment of cancer;The wording HERTUZU has no meaning in a foreign language.;

HERTUZU

Pharmaceutical preparations for the treatment of cancer;

HERZUMA

Pharmaceutical preparations for the treatment of cancer;The wording HERZUMA has no meaning in a foreign language.;

HERZUMA

Biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; cancer treatment preparations;

HUEXMA

Pharmaceutical preparations for the treatment of autoimmune diseases;

HUUTELA

Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticals, namely, pharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticals, namely, pharmaceutical preparations for the treatment of HIV/AIDS;

HYVALTUS

Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticals, namely, pharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticals, namely, pharmaceutical preparations for the treatment of HIV/AIDS;

KOVDAVIO

Pharmaceutical preparations for the treatment of COVID-19; antibodies for medical purposes, namely, immunological antibodies for medical purposes; Pharmaceuticals, namely, COVID-19 Pharmaceuticals; drugs for medical purposes for the treatment of COVID-19;

ND NEARDOC

The mark consists of the stylized wording ND NEARDOC with the letters ND and the dots above these letters in the colors green and light green.  The wording NEARDOC is in the color dark grey. ;The color(s) green, light green, dark grey is/are claimed as a feature of the mark.;Home-visit nursing care; health care; provision of health information; hospital services; hospitals, namely, hospital services for persons with physical or cognitive disabilities or impairments; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; ambulant medical care; telemedicine services; provision of medical information from a web site; hygienic and beauty care; medical and health care services; medical and pharmaceutical consultation; nursing, medical; medical care; medical consultations; medical clinic services; medical information; medical information services provided via the Internet; individual medical counselling services provided to patients;